Broadwood Partners seeks to remove three STAAR Surgical directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
December 2, 2025 4:15 PM ESTPursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process
Broadwood Seeks to Remove the Directors Most Responsible for the Flawed Sale Process: Board Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Arthur Butcher
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the Special Meeting) at STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
